Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 601

1.

The FOXP3+ subset of human CD4+CD8+ thymocytes is immature and subject to intrathymic selection.

Tuovinen H, Pekkarinen PT, Rossi LH, Mattila I, Arstila TP.

Immunol Cell Biol. 2008 Aug-Sep;86(6):523-9. doi: 10.1038/icb.2008.36. Epub 2008 May 27.

PMID:
18504453
2.

Cutting edge: human CD4-CD8- thymocytes express FOXP3 in the absence of a TCR.

Tuovinen H, Kekäläinen E, Rossi LH, Puntila J, Arstila TP.

J Immunol. 2008 Mar 15;180(6):3651-4.

3.

Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice.

Chen X, Priatel JJ, Chow MT, Teh HS.

J Immunol. 2008 May 1;180(9):5973-82.

4.

Recent thymic origin, differentiation, and turnover of regulatory T cells.

Mabarrack NH, Turner NL, Mayrhofer G.

J Leukoc Biol. 2008 Nov;84(5):1287-97. doi: 10.1189/jlb.0308201. Epub 2008 Aug 5.

PMID:
18682578
5.

The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.

Javeed A, Zhang B, Qu Y, Zhang A, Sun C, Zhang L, Liu J, Zeng C, Zhao Y.

Transpl Immunol. 2009 Mar;20(4):253-60. doi: 10.1016/j.trim.2008.12.001. Epub 2009 Jan 13.

PMID:
19146957
6.

Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.

Siegmund K, Rückert B, Ouaked N, Bürgler S, Speiser A, Akdis CA, Schmidt-Weber CB.

J Immunol. 2009 Feb 15;182(4):2124-30. doi: 10.4049/jimmunol.0802271.

7.

Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.

Aarts-Riemens T, Emmelot ME, Verdonck LF, Mutis T.

Eur J Immunol. 2008 May;38(5):1381-90. doi: 10.1002/eji.200737590.

8.

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.

Lim A, French MA, Price P.

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):248-57. doi: 10.1097/QAI.0b013e3181a74fad.

PMID:
19363449
9.

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.

Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.

Gastroenterology. 2007 Jun;132(7):2328-39. Epub 2007 Apr 14.

PMID:
17570208
10.

Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.

Jacobo P, Guazzone VA, Jarazo-Dietrich S, Theas MS, Lustig L.

J Reprod Immunol. 2009 Jul;81(1):44-54. doi: 10.1016/j.jri.2009.04.005. Epub 2009 Jun 10.

PMID:
19520436
11.

Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.

Kaur G, Goodall JC, Jarvis LB, Hill Gaston JS.

Mol Immunol. 2010 Nov-Dec;48(1-3):321-32. doi: 10.1016/j.molimm.2010.07.008. Epub 2010 Aug 5.

PMID:
20688398
12.

The CD4(+)CD8(+) and CD4(+) subsets of FOXP3(+) thymocytes differ in their response to growth factor deprivation or stimulation.

Lehtoviita A, Rossi LH, Kekäläinen E, Sairanen H, Arstila TP.

Scand J Immunol. 2009 Oct;70(4):377-83. doi: 10.1111/j.1365-3083.2009.02307.x.

13.

Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.

Knol AC, Lemaître F, Pandolfino MC, Volteau C, Quéreux G, Saiagh S, Khammari A, Viguier M, Dréno B.

Exp Dermatol. 2008 May;17(5):436-45. doi: 10.1111/j.1600-0625.2007.00681.x. Epub 2008 Feb 27.

PMID:
18312383
14.

Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity?

Genre J, Errante PR, Kokron CM, Toledo-Barros M, Câmara NO, Rizzo LV.

Clin Immunol. 2009 Aug;132(2):215-21. doi: 10.1016/j.clim.2009.03.519. Epub 2009 Apr 25.

PMID:
19394278
15.

Differentiation of human thymic regulatory T cells at the double positive stage.

Nunes-Cabaço H, Caramalho I, Sepúlveda N, Sousa AE.

Eur J Immunol. 2011 Dec;41(12):3604-14. doi: 10.1002/eji.201141614. Epub 2011 Oct 24.

16.

Morpholino antisense oligonucleotide-mediated gene knockdown during thymocyte development reveals role for Runx3 transcription factor in CD4 silencing during development of CD4-/CD8+ thymocytes.

Ehlers M, Laule-Kilian K, Petter M, Aldrian CJ, Grueter B, Würch A, Yoshida N, Watanabe T, Satake M, Steimle V.

J Immunol. 2003 Oct 1;171(7):3594-604.

17.

Expression of CCR9 beta-chemokine receptor is modulated in thymocyte differentiation and is selectively maintained in CD8(+) T cells from secondary lymphoid organs.

Carramolino L, Zaballos A, Kremer L, Villares R, Martín P, Ardavín C, Martínez-A C, Márquez G.

Blood. 2001 Feb 15;97(4):850-7.

18.

Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.

Fattorossi A, Battaglia A, Buzzonetti A, Minicuci G, Riso R, Peri L, Scambia G, Evoli A.

J Clin Immunol. 2008 Mar;28(2):194-206. Epub 2007 Nov 14.

PMID:
18000743
19.

No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.

Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D, Haller M, Rockell J, Gottlieb P, Clare-Salzler M, Atkinson M.

Diabetes. 2007 Mar;56(3):604-12.

20.

Foxp3 induction in human and murine thymus precedes the CD4+ CD8+ stage but requires early T-cell receptor expression.

Nunes-Cabaço H, Ribot JC, Caramalho I, Serra-Caetano A, Silva-Santos B, Sousa AE.

Immunol Cell Biol. 2010 Jul;88(5):523-8. doi: 10.1038/icb.2010.4. Epub 2010 Feb 9.

PMID:
20142839

Supplemental Content

Support Center